AstraZeneca (AZN) PT Lowered to $88 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Etzer Darout lowered the price target on AstraZeneca (NASDAQ: AZN) to $88.00 (from $89.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
